APCO Immunotherapy (A.I)

for

COVID-19

• Preventing viral infection by boosting the immunity of the epithelial mucosal barrier to stop the virus from passing through and infecting body cells.

• Eliminating the viruses by enhancing the efficacy of killer T cell when the viruses have infected body cells.

A.I

boosts Th1 and Th17 several times in 15 days with 4 capsules/day.

• Th1 secretes interferon gamma and TNF alpha both of which are anti-viral.

• Th17 secretes interleukin-17 and interleukin-22 significantly to prevent the virus from passing through mucosal barrier to infect body cells.

This is : The most effective way to prevent virus infection.

Its efficacy in preventing the virus infection has been proven by the obvious drop in the number of consumers infected with the flu after using APCO innovation :

> Among 52 HIV infected children at Baan Gerda Orphanage who took 4-6 capsules/day

> The number of children who caught the flu more than 3 times/year dropped from 79% to 0%.

> The number of children who were not infected by the flu all year round increased from 0% to 83%..

Its efficacy in preventing the virus infection has been proven by the obvious drop in the number of consumers infected with the flu after using APCO innovation :

> Among 303 general consumers who took 2-9 capsules/day

> The number of consumers who caught the flu more than 3 times/year dropped from 46% to 4.3%.

> The number of consumers who were not infected by the flu all year round increased from 5.9% to 58%..




Both Th1 and Th17 enhance the activity of killer T cell to disintegrate the virus infected cells. This is :

The most effective way to eliminate the viruses.

Rapidly reducing HIV load in one month : from 1,090,000 to 850 copies/ml, from 1,787,091 to 46 copies/ml (-99.9%)

Reducing HIV to the undetected level without using anti-viral drug (HIV Functional Cure)

Reducing HIV and saving life of patients in the final stage of AIDS.

“APCO immunotherapy (A.I) both prevents and eliminates viruses.”


Teleconference China-Thai COVID-19 Pneumonia Prevention and Clinical Protocols Academic Dialogue APCO Bangkok Office 25 February 2020

APCO has appointed Exclusive Distributor of APCO Immunotherapy (A.I.) in China, Hong Kong, Taiwan to increase immunity to prevent the virus. COVID-19 , aiming to sell 30,000 bottles per month.


HOW APCO Immunotherapy (A.I) Controlling COVID-19

 

APCO Immunotherapy (A.I) for HIV/AIDS

 

APCO Immunotherapy (A.I) for Cancer

 

About Us

Asian Phytoceutical Public Company Limited (APCO Bangkok Office)

Address: 30 Floor AIA Capital Center Bldg., 89 Ratchadaphisek Road.

Dindaeng Dindaeng District, Bangkok 10400

Kingdom of Thailand

Contact Us

Email: [email protected]

Web Site: http://apco.co.th

Telephone: +662 646 4881

Fax : +662 646 4898 - 9